查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1877462

即時凝血檢測市場：依檢測類型、技術、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Point-of-Care Coagulation Testing Market, By Test Type, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 390 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年即時凝血檢測市場規模為 27.9878 億美元，從 2025 年到 2032 年將以 6.5% 的複合年成長率成長。

床邊凝血檢測 (POCCT) 透過提供快速的床邊血液凝固分析，協助即時、數據驅動的臨床決策，進而革新醫療保健產業。在急診、手術和出血性疾病等情況下，對快速、準確的凝血診斷的需求日益成長，以實現個人化的患者護理。連接性、小型化和人工智慧整合的持續創新推動了市場成長。此外，市場正經歷著向複雜黏彈性檢測的顯著趨勢，這種檢測能夠提供全面的血栓特徵，從而改善創傷和手術預後。居家抗凝血監測的推廣應用蘊藏著巨大的成長機遇，使慢性病患者更容易管理治療。然而，當檢測在中心實驗室之外進行時，如何維持一致且嚴格的品質控制仍然是市場面臨的挑戰。

即時凝血檢測市場－市場動態

心血管疾病日益普遍

在全球範圍內，心血管疾病，例如深部靜脈栓塞、中風和心房顫動，是導致死亡和發病的主要原因。根據世界衛生組織（世衛組織）2025年7月發布的資料，心血管疾病是全球首要的死因。 2022年，全球約有1,980萬人死於心血管疾病，約佔總死亡人數的32%。其中，心臟病發作和中風佔85%。此外，在2021年因非傳染性疾病導致的1,800萬例過早死亡（70歲以下）中，至少有38%是由心血管疾病造成的。因此，為了預防出血或血栓形成等潛在的致命副作用，有效的抗凝血治療需要常規監測凝血參數，包括凝血酶原時間（PT/INR）和活化凝血時間（ACT）。然而，傳統實驗室檢測的集中式基礎設施和較長的周轉時間可能會導致重要的治療選擇被延誤。床邊凝血檢測（POC​​凝血檢測）解決了這些難題，可在幾分鐘內於患者床邊、手術室、急診室甚至家中提供檢測結果。除了減少住院次數外，這也有助於提高患者的依從性，尤其對於長期服用抗凝血藥物的患者。

即時凝血檢測市場區隔分析：

全球即時凝血檢測市場按檢測類型、技術、最終用戶和地區進行細分。

根據檢測類型，市場可分為五大類：凝血酶原時間 (PT/INR) 檢測、活化凝血時間 (ACT) 檢測、活化部分凝血活酶時間 (aPTT) 檢測、黏彈性檢測（如 TEG、ROTEM 等）以及其他特殊凝血檢測。 PT/INR 用於監測外源性凝血途徑和華法林治療，ACT 用於指導高劑量肝素治療，aPTT 用於檢測內源性凝血途徑和肝素治療，TEG/ROTEM 用於分析血栓動力學，其他檢測則針對特定疾病。

根據技術，市場可分為三大類：光學技術、機械技術和電化學技術。光學技術透過測量光線變化或模式來檢測凝血；機械技術透過評估血液黏度或流動情況來指示血栓形成；電化學技術則透過檢測凝血過程中的電變化來判斷凝血情況。

即時凝血檢測市場—地域洞察

北美市場佔據主導地位，這主要得益於先進的醫療基礎設施、廣泛的應用以及出血性疾病的高發生率。此外，北美地區對快速診斷、抗凝血治療管理以及醫療保健領域的大力投入等因素，也使得床邊凝血檢測得到廣泛應用。英國和其他西方國家在歐洲市場正經歷快速成長，這得益於政府的鼓勵性措施、慢性病自我監測的普及以及對快速可靠監測的需求，尤其是在抗凝血治療和手術方面。亞太地區預計將成為成長最快的地區，這主要得益於醫療保健覆蓋範圍的擴大、心血管凝血檢測的強制性要求以及需要快速管理出血和血栓性疾病的患者群體不斷擴大。拉丁美洲的床邊凝血檢測市場也在穩定成長，這得益於疾病快速檢測和有效管理的投資。中東和非洲的需求也在不斷成長，這主要歸功於卒中管理項目的開展以及專科中心對基於試劑盒的凝血檢測的日益重視。

即時凝血檢測市場－競爭格局：

即時凝血檢測 (POC) 市場競爭激烈且成長迅速，其主要驅動力是臨床和家庭環境中對快速、準確的凝血評估日益成長的需求。主要參與者包括羅氏 (F. Hoffmann-La Roche Ltd.)、雅培 (Abbott Laboratories)、西門子醫療 (Siemens Healthineers)、希森美康 (Sysmex Corporation) 和 Werfen，它們都致力於透過微流控、生物感測器和人工智慧整合等先進技術來擴展產品組合。這些公司在研發、創新和策略合作方面投入巨資，以提高設備的準確性、便攜性和連接性，從而實現與醫療保健系統的無縫整合。例如，2022 年 1 月，羅氏宣佈在部分國家推出 CE 認證的 cobas pulse 系統。這款新系統代表了羅氏診斷最新一代互聯即時解決方案，專為專業血糖管理而設計。此外，該市場呈現半整合結構，少數幾家主導製造商佔據了相當大的市場佔有率，而眾多規模較小的公司則在細分市場中競爭。

目錄

第1章：即時凝血檢測市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 即時凝血檢測市場概覽（依檢測類型分類）
    • 即時凝血檢測市場技術概覽
    • 按最終用戶分類的即時凝血檢測市場概覽
    • 各國即時凝血檢測市場概況
    • 即時凝血檢測市場區域概覽
  • 競爭洞察

第3章：即時凝血檢測市場主要趨勢

  • 即時凝血檢測市場促進因素
    • 市場促進因素的影響分析
  • 即時凝血檢測市場限制因素
    • 市場限制因素的影響分析
  • 即時凝血檢測市場機遇
  • 即時凝血檢測市場未來趨勢

第4章：即時凝血檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：即時凝血檢測市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：即時凝血檢測市場概況

  • 即時凝血檢測市場佔有率分析，2024年
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：即時凝血檢測市場－依檢測類型分類

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 凝血酶原時間（PT/INR）檢測
    • 活化凝血時間 (ACT) 檢測
    • 活化部分凝血酶原時間 (aPTT) 檢測
    • 黏彈性測試（TEG、ROTEM 等）
    • 其他特殊凝血試驗

第8章：即時凝血檢測市場－依技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 光學技術
    • 機械技術
    • 電化學技術

第9章：即時凝血檢測市場－依最終使用者分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 門診手術中心（ASC）
    • 診斷實驗室
    • 家庭護理機構
    • 其他

第10章：即時凝血檢測市場－依地域分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美即時凝血檢測主要生產商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（依測試類型分類）
    • 北美市場規模及預測（依技術分類）
    • 北美市場規模及預測（依最終用戶分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲即時凝血檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（依測試類型分類）
    • 歐洲市場規模及預測（依技術分類）
    • 歐洲市場規模及預測（依最終用戶分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區即時凝血檢測主要生產商
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（依測試類型分類）
    • 亞太市場規模及預測（依技術分類）
    • 亞太市場規模及預測（依最終用戶分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲即時凝血檢測主要生產商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（按測試類型分類）
    • 拉丁美洲市場規模及預測（依技術分類）
    • 拉丁美洲市場規模及預測（按最終用戶分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲即時凝血檢測主要生產商
    • MEA市場規模及預測（依國家/地區分類）
    • MEA市場規模及預測（依測試類型分類）
    • MEA市場規模及預測（依技術分類）
    • MEA市場規模及預測（依最終用戶分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第11章：主要供應商分析－即時凝血檢測產業

  • 競爭格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Siemens Healthineers
    • Abbott Laboratories
    • Sysmex Corporation
    • Werfen
    • Danaher Corporation
    • Medtronic
    • HemoSonics, LLC
    • Danaher Corporation
    • Trinity Biotech
    • F. Hoffmann-La Roche Ltd

第12章：360度AnalystView

第13章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5718

Point-of-Care Coagulation Testing Market size was valued at US$ 2,798.78 Million in 2024, expanding at a CAGR of 6.5% from 2025 to 2032.

Point-of-Care Coagulation Testing (POCCT) is revolutionizing healthcare by providing rapid, bedside blood clotting analysis that enables immediate, data-driven clinical decisions. The rising demand for fast, accurate coagulation diagnostics to personalize patient care in emergencies, surgeries, and bleeding disorders, supported by continuous innovation in connectivity, miniaturization, and AI integration is boosting market growth. Additionally, the market is witnessing a significant trend toward sophisticated viscoelastic testing that offers a comprehensive clot profile, improving trauma and surgical outcomes. A major growth opportunity lies in expanding home-based anticoagulant monitoring, empowering patients with chronic conditions to manage therapy conveniently. However, the market faces challenges in maintaining consistent and rigorous quality control when testing occurs outside centralized laboratory settings.

Point-of-Care Coagulation Testing Market- Market Dynamics

Growing prevalence of cardiovascular diseases

Globally, cardiovascular diseases such deep vein thrombosis, stroke, and atrial fibrillation are leading causes of death and morbidity. According to data published in July 2025, by World Health Organization (WHO), globally, cardiovascular diseases (CVDs) constitute the primary cause of mortality. About 19.8 million deaths worldwide in 2022 were attributed to CVDs, accounting for about 32% of the total number of deaths. Heart attacks and strokes were the cause of 85% of these fatalities. Moreover, CVDs were responsible for at least 38% of the 18 million premature deaths (those under 70) that occurred in 2021 as a result of noncommunicable diseases. Thus, in order to prevent potentially fatal side effects like bleeding or thrombosis, effective anticoagulation therapy necessitates routine monitoring of clotting parameters including Prothrombin Time (PT/INR) and Activated Clotting Time (ACT). However, centralized infrastructure and longer turnaround times associated with traditional laboratory testing may cause important treatment choices to be postponed. These obstacles are addressed by POC coagulation tests, which provide results in a matter of minutes at the patient's bedside, operating room, emergency hospital, or even their home. In addition to decreasing hospitalizations, this also improves patient adherence, particularly for long-term anticoagulant users.

Point-of-Care Coagulation Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2025-2032)

Based on Test Type segmentation, Prothrombin Time (PT/INR) Testing is predicted to show maximum market share in the year 2024

Based on Technology segmentation, Optical Technology is the leading Technology in 2024

Based on End User segmentation, Hospitals & Clinics is the leading Technology in 2024

On the basis of region, North America is the leading revenue generator in 2024

Point-of-Care Coagulation Testing Market- Segmentation Analysis:

The Global Point-of-Care Coagulation Testing Market is segmented on the basis of Test Type, Technology, End User, and Region.

The market is divided into five categories based on Test Type: Prothrombin Time (PT/INR) Testing, Activated Clotting Time (ACT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Viscoelastic Testing (TEG, ROTEM, etc.), and Other Specialized Coagulation Tests. PT/INR monitors extrinsic pathway and warfarin, ACT guides high-dose heparin, aPTT checks intrinsic pathway and heparin, TEG/ROTEM analyze clot dynamics, others target specific disorders.

The market is divided into three categories based on Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology. Optical technology measures light changes or patterns to detect clotting; mechanical technology assesses blood viscosity or movement to indicate clot formation; electrochemical technology detects electrical changes during coagulation.

Point-of-Care Coagulation Testing Market- Geographical Insights

North America dominates the market, driven by advanced healthcare infrastructure, widespread adoption, and a high prevalence of bleeding disorders. Additionally, North America exhibits widespread adoption of point-of-care coagulation testing due to the emphasis on rapid diagnosis, anticoagulant therapy management, and strong healthcare investments, among others. The UK and other Western nations are experiencing rapid growth in Europe as a result of encouraging government measures, increasing adoption of self-monitoring for chronic conditions, and demand for rapid, reliable monitoring, especially in anticoagulation therapy and surgery. Asia-Pacific is expected to witness the fastest growth, fueled by expanding healthcare access, mandates for cardiovascular clotting tests, and larger patient populations requiring rapid management of bleeding and thrombotic disorders. The Latin American point-of-care coagulation testing market is expanding steadily, owing to investment in rapid disease detection and effective management. Middle East and Africa, show rising demand, due to stroke management programs and an increasing focus on cartridge-based coagulation tests in specialty centers.

Point-of-Care Coagulation Testing Market- Competitive Landscape:

The point-of-care (POC) coagulation testing market is highly competitive and rapidly growing, driven by increasing demand for quick, accurate clotting assessments in clinical and home settings. Key players include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, and Werfen, all focusing on expanding product portfolios through advanced technologies such as microfluidics, biosensors, and AI integration. These companies invest significantly in research, innovation, and strategic collaborations to enhance device accuracy, portability, and connectivity, enabling seamless integration with healthcare systems. For instance, in January 2022, F. Hoffmann-La Roche Ltd has announced the launch of the cobas pulse system in select countries with CE Mark approval. This new system represents Roche Diagnostics' latest generation of connected point-of-care solutions designed specifically for professional blood glucose management. Additionally, the market is characterized by a semi-consolidated structure, with a few dominant manufacturers holding substantial shares while numerous smaller companies compete in niche segments.

Recent Developments:

In July 2024, Werfen introduced GEM Premier 7000 with Intelligent Quality Management 3 (iQM3). The GEM Premier 7000 with iQM3 represented a breakthrough in blood gas testing, and offered hemolysis detection for first time at the point-of-care (POC).

In March 2023, Siemens Healthineers and Sysmex Corporation have established a global Original Equipment Manufacturer (OEM) agreement to supply hemostasis instruments and reagents. The strengthened collaboration leveraged their 25-year partnership to improve patient outcomes by advancing hemostasis testing technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Siemens Healthineers
  • Abbott Laboratories
  • Sysmex Corporation
  • Werfen
  • Danaher Corporation
  • Medtronic
  • HemoSonics, LLC
  • Danaher Corporation
  • Trinity Biotech
  • F. Hoffmann-La Roche Ltd
  • Others

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prothrombin Time (PT/INR) Testing
  • Activated Clotting Time (ACT) Testing
  • Activated Partial Thromboplastin Time (aPTT) Testing
  • Viscoelastic Testing (TEG, ROTEM, etc.)
  • Other Specialized Coagulation Tests

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories
  • Home Care Settings
  • Others

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Point-of-Care Coagulation Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Point-of-Care Coagulation Testing Market Snippet by Test Type
    • 2.1.2. Point-of-Care Coagulation Testing Market Snippet by Technology
    • 2.1.3. Point-of-Care Coagulation Testing Market Snippet by End User
    • 2.1.4. Point-of-Care Coagulation Testing Market Snippet by Country
    • 2.1.5. Point-of-Care Coagulation Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Point-of-Care Coagulation Testing Key Market Trends

  • 3.1. Point-of-Care Coagulation Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Point-of-Care Coagulation Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Point-of-Care Coagulation Testing Market Opportunities
  • 3.4. Point-of-Care Coagulation Testing Market Future Trends

4. Point-of-Care Coagulation Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Point-of-Care Coagulation Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Point-of-Care Coagulation Testing Market Landscape

  • 6.1. Point-of-Care Coagulation Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Point-of-Care Coagulation Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Prothrombin Time (PT/INR) Testing
    • 7.1.3. Activated Clotting Time (ACT) Testing
    • 7.1.4. Activated Partial Thromboplastin Time (aPTT) Testing
    • 7.1.5. Viscoelastic Testing (TEG, ROTEM, etc.)
    • 7.1.6. Other Specialized Coagulation Tests

8. Point-of-Care Coagulation Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Optical Technology
    • 8.1.3. Mechanical Technology
    • 8.1.4. Electrochemical Technology

9. Point-of-Care Coagulation Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Home Care Settings
    • 9.1.6. Others

10. Point-of-Care Coagulation Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Point-of-Care Coagulation Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Point-of-Care Coagulation Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Point-of-Care Coagulation Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Point-of-Care Coagulation Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Point-of-Care Coagulation Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Point-of-Care Coagulation Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Siemens Healthineers
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Sysmex Corporation
    • 11.2.4. Werfen
    • 11.2.5. Danaher Corporation
    • 11.2.6. Medtronic
    • 11.2.7. HemoSonics, LLC
    • 11.2.8. Danaher Corporation
    • 11.2.9. Trinity Biotech
    • 11.2.10. F. Hoffmann-La Roche Ltd

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us